- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07851350
PROPOSAL FOR A PREOPERATIVE FUNCTIONAL OPTIMIZATION PATHWAY FOR PATIENTS CANDIDATE FOR MAJOR SURGERY (CARDIAC AND ABDOMINAL ONCOLOGY) (PRIME CARE)
PRehabilitation With Integrated and Multimodal Evaluation in Cardiac and Abdominal majoR surgEry (PRIME CARE) A Proposed Pathway for Preoperative Functional Optimization in Candidates for Major Surgery
The study aims to evaluate a prehabilitation protocol for patients undergoing cardiac and abdominal surgery. The project for a preparation program for cardiac surgery was developed within the framework of ERAS (Enhanced Recovery After Surgery), which aims to ensure optimal recovery after surgery and a Surgery), which aims to ensure optimal recovery after surgery and an early and safe return to daily activities.
The study focuses on the preoperative phase, with the introduction of the concept of prehabilitation, i.e., a program to enhance the functional abilities of individuals in preparation for major surgery. The study focuses on the preoperative phase, introducing the concept of prehabilitation, i.e., a program to enhance the functional abilities of individuals in preparation for major surgery, such as cardiac surgery, on an elective basis.
This program, which currently represents best clinical practice, lasts four weeks and addresses several areas: strengthening respiratory and muscular functions, optimizing nutrition, and cognitive stimulation. Patients will be assessed at enrollment and up to 180 days post-surgery to evaluate their clinical status compared to pre-surgery on these four aspects mentioned above.
Aperçu de l'étude
Statut
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Massimo Stella, MD
- Numéro de téléphone: 0039 0332393447
- E-mail: maxstella95@gmail.com
Lieux d'étude
-
-
-
Varese, Italie, 21100
- Actif, ne recrute pas
- ASST Sette Laghi
-
-
VA
-
Varese, VA, Italie, 21052
- Recrutement
- Ospedale di Circolo
-
Contact:
- Massimo Stella, MD
- Numéro de téléphone: +39 0332 393447
- E-mail: maxstella95@gmail.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
This prospective, observational, single-center study will enroll approximately 50 adult patients (≥18 years old) undergoing elective cardiac or major abdominal surgery at Ospedale di Circolo e Fondazione Macchi, Varese, Italy. Eligible patients for abdominal surgery must have ASA I-III and PS ECOG ≤2. Key exclusion criteria include emergency surgery, unstable angina, malignant arrhythmias, severe or very severe COPD, dementia, pregnancy, or inability to provide informed consent. Participants will be screened by the surgical team and followed during a personalized prehabilitation program starting about one month before surgery.
La description
Inclusion Criteria:
- Elective major abdominal surgery or elective cardio surgery
- American Society of Anaesthesiologists Physical Status Classification ≤ 3
- Performance Status according to ECOG Scale ≤ 2
Exclusion Criteria:
- Emergency surgery
- Unstable angina
- Malignant arrythmias
- Severe/ very severe COPD
- Dementia
- Pregnancy
- Inability to provide informed consent
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: CASE_ONLY
- Perspectives temporelles: PROSPECTIVE
Cohortes et interventions
Groupe / Cohorte |
|---|
|
Eligible patients for major surgery
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
10% improvement from baseline at 6-minutes-walking-test-distance
Délai: From enrollment to the date of surgery
|
The primary outcome of this study is to evaluate whether prehabilitation translates into an improvement in quality of life before surgery, assessed in terms of functional status. This objective is assessed using the 6-minute walking distance test. A significant improvement is considered to be a positive delta in the six-minute walking test of ≥10% obtained at the assessment performed on the day of admission compared to the value recorded during the first assessment. |
From enrollment to the date of surgery
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Increased thickness of the quadriceps femoris muscle
Délai: From enrollment to the date of surgery
|
An increase in the thickness of the quadriceps femoris muscle will be assessed via ultrasound as a direct sign of an increase in the number and volume of muscle fibres |
From enrollment to the date of surgery
|
|
Increased cross-sectional area of the quadriceps femoris muscle
Délai: From enrollment to the date of surgery
|
An increase in the cross-sectional area of the quadriceps femoris muscle will be assessed via ultrasound as a direct sign of an increase in the number and volume of muscle fibres |
From enrollment to the date of surgery
|
|
Increased pennation angle of the quadriceps femoris muscle
Délai: From enrollment to the date of surgery
|
An increase in the pennation angle of the quadriceps femoris muscle, assessed by ultrasound, is a direct sign of increased contractility of the muscle itself, and therefore an indirect index of an increase in muscle strength. |
From enrollment to the date of surgery
|
|
Change in Pulmonary Function Parameters
Délai: From enrollment to the date of surgery
|
Change in pulmonary volumes including Forced Expiratory Volume in 1 second (FEV1), Forced Vital Capacity (FVC), and Tiffeneau Index (FEV1/FVC ratio) measured through spirometry at baseline and after completion of prehabilitation. |
From enrollment to the date of surgery
|
|
Improvement in Functional Performance Tests
Délai: From enrollment to the date of surgery
|
Change in performance at Handgrip Strength test (Newton), and Maximal Isometric Strength test (Newton), assessed at baseline and after the prehabilitation program. An increase in the value indicates an improvement in functional capacity. |
From enrollment to the date of surgery
|
|
Change in Diaphragmatic Excursion
Délai: From enrollment to the date of surgery
|
Variation in diaphragmatic movement amplitude assessed by ultrasound before and after the prehabilitation period. |
From enrollment to the date of surgery
|
|
Change in Health-Related Quality of Life (EQ-5D-5L Index)
Délai: From enrollment to 180 days after discharge
|
Variation in patient-reported quality of life as assessed by the EQ-5D-5L questionnaire. The index score will be compared between baseline and preoperative assessment after prehabilitation and also at 30 days and 180days after discharge |
From enrollment to 180 days after discharge
|
|
Incidence of Postoperative Delirium in the Intensive Care Unit
Délai: Perioperative/Periprocedural
|
Occurrence of postoperative delirium evaluated daily during ICU stay using the Confusion Assessment Method for the ICU (CAM-ICU). |
Perioperative/Periprocedural
|
|
Change in Nutritional and Biochemical Markers
Délai: From enrollment to 30 days after discharge
|
Variation in nutritional status indicators assessed through blood biochemical parameters (albumin, prealbumin, total protein, lymphocyte count, iron, transferrin, vitamin B12, folic acid, hemoglobin,) before the prehabilitation program, after the prehabilitation program and at 30 days after discharge |
From enrollment to 30 days after discharge
|
|
Length of Stay in Intensive Care Unit
Délai: Perioperative/Periprocedural
|
Duration of ICU stay (in days) from postoperative admission to ICU discharge. |
Perioperative/Periprocedural
|
|
Total Hospital Length of Stay
Délai: Perioperative/Periprocedural
|
Total duration of hospitalization (in days) from admission for surgery to hospital discharge. |
Perioperative/Periprocedural
|
|
180-Day Mortality
Délai: From discharge to 180 days after surgery
|
All-cause mortality evaluated at 180 days after surgery. |
From discharge to 180 days after surgery
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 25/2025
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
- CIF
- ANALYTIC_CODE
- RSE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .